New York - It's a safe bet that Dr Renu Virmani (CV Path Institute, Gaithersburg, MD), when charged with the task of predicting the future of invasive therapy for the treatment of high-risk, ...

Amid growing evidence that the same abnormal clumping of proteins in Alzheimer's disease also contributes to type-2 diabetes, scientists are reporting discovery of a potent new compound that reduces ...

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop. There is also much evidence that these three diseases are interconnected ...

Cholesterol manufactured in the brain appears to play a key role in the development of Alzheimer’s disease, new research indicates. Scientists from the University of Virginia School of Medicine and ...

"These data support the hypothesis that a primary mechanism for apoE-mediated plaque formation may be a result of apoE aggregation, as preferentially targeting of apoE aggregates with therapeutic ...

A new PET tracer proved for the first time that it can be used to identify brain activity involved in the formation of plaque in people with cognitive impairment and Alzheimer’s disease, according to ...

A new study led by researchers from VIB and KU Leuven shows that immune cells called microglia can actively promote the formation of plaques in Alzheimer's disease, challenging the long-standing view ...

Autophagy, a key cellular auto-cleaning mechanism, mediates the formation of amyloid beta plaques, one of the hallmarks of Alzheimer's disease. It might be a potential drug target for the treatment of ...

Since the differentiation of monocytes into macrophages is a key step in the development of atherosclerotic plaques, Johnsen et al. considered whether monocyte activity is associated with the risk of ...

Researchers at Lund University in Sweden have used the MAX IV synchrotron in Lund - the strongest of its kind in the world - to produce images that predate the formation of toxic clumps of ...